Obermann and colleagues have recently reported that pregabalin, a new drug that reduces release of excitatory neurotransmitters, shows promise as a treatment for TN. Their prospective, open-label ...

Purpose: The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosage and administration of pregabalin are reviewed. Summary: Pregabalin is the first drug to receive approved ...

b Patients taking 25-50 mg once daily should take one supplemental pregabalin dose of 50 or 75 mg after hemodialysis. c Patients taking 75 mg once daily should take one supplemental pregabalin ...

Pregabalin was the drug which was most mentioned in drug-related deaths across Northern Ireland in 2023, according to official statistics. It was mentioned in 67 of 169 drug-related deaths.